Canada Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis

Need more information?

Inquiry

We Offer You…

» Online support by email or telephone 24×7

» Assured confidentiality, safety and security as we operate through most trusted and reliable online payment systems

» Instant delivery of requested content in the desired form (PDF/PPT/Word Doc) to your provided email address after receiving the full payment.

» A Minimum Content Delivery initiation time of 9 hours

» An opportunity to be considered as an Expert Panel Member

» The provision of live, domain-specific updates

Canada Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis

  • 174 Pages | 28-Apr-18 | Format:PDF | Last Updated: Updation in process

  • “GervanoRA’s “Canada Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis” provides an in-depth analysis about Canada’s Healthcare industry imparting complete information on the Regulatory system in Canada, Reimbursement system, Pharmaceutical market and Medical Device market. Detailed information has been provided on the approval process, manufacturing license process, Import and Export License process and intellectual property rights related to the drugs and medical devices. Report also focuses on the details related to the reimbursement process, insurance providers and drug pricing policies. Comprehensive insights on Canada’s Pharmaceutical and Medical Device industry aids the clients in identifying the growing opportunities and hence assists in developing any business strategy for developing commercial partnerships. Our report exclusively focuses on healthcare market opportunity assessment by identifying the emerging pharmaceutical and medical device companies which helps the client in knowing its upcoming competitors in the healthcare domain. Complete information related to below aspects have been provided in this report.
    • Pharmaceutical Exports and Imports
    • Prescription Drug Market
    • Patented Drug Market
    • Generic Drug Market
    • Over the Counter Drug Market
    • Pharmaceutical R&D Spending
    • Medical Device Recalls
    It also focuses on the major active key players in the healthcare industry by identifying the key companies involved in the Pharma and Medical Device Sector. The Political, Economic, Social, Technology, Legal and Environment (PESTLE) Analysis helps in the overall understanding of Canada.

  • TABLE OF CONTENTS
    1. INTRODUCTION
    1.1.REPORT DESCRIPTION
    1.2 METHODOLOGY
    1.3 RELATED UPCOMING REPORTS
    1.4 ABOUT US: GERVANORA DATA SERVICES
    1.7 CANADA HEALTHCARE MARKET SNAPSHOT, 2019-2027
    2. EXECUTIVE SUMMARY
    2.1 KEY EVENTS IN CANADA HEALTHCARE MARKET
    2.2 MAJOR FINDINGS
    2.2.1 MARKET DRIVERS
    2.2.2 RESTRAINTS
    2.2.3 UNMET NEEDS AND OPPORTUNITIES
    3. REGULATORY SYSTEM
    3.1 OVERVIEW OF REGULATORY AGENCIES
    3.2 APPROVAL PROCESS OF PATENTED DRUGS, GENERIC DRUGS, BIOLOGICS AND BIOSIMILARS
    3.3 APPROVAL PROCESS OF MEDICAL DEVICES
    3.4 MANUFACTURING LICENSE PROCESS FOR DRUGS
    3.5 MANUFACTURING LICENSE PROCESS FOR MEDICAL DEVICES
    3.6 IMPORT AND EXPORT LICENSE PROCESS FOR DRUGS AND MEDICAL DEVICES
    3.7 INTELLECTUAL PROPERTY RIGHTS- PATENT, TRADEMARK
    4. REIMBURSEMENT SYSTEM
    4.1 REIMBURSEMENT PROCESS
    4.2 INSURANCE PROVIDERS
    4.3 PATIENT SHARE IN HEALTHCARE SPENDING
    4.4 DRUG PRICING POLICIES
    5. CANADA PHARMACEUTICAL MARKET
    5.1 PHARMACEUTICAL MARKET SNAPSHOT AND FORECAST
    5.2 PHARMACEUTICAL EXPORTS AND IMPORTS
    5.3 PRESCRIPTION DRUG, MARKET SIZE AND FORECAST
    5.4 PATENTED DRUG MARKET SIZE AND FORECAST
    5.5 GENERIC DRUG MARKET OVERVIEW AND FORECAST
    5.6 OVER THE COUNTER DRUG MARKET SIZE AND FORECAST
    5.7 MAJOR DISEASES AND ECONOMIC BURDEN
    5.8 MAJOR COMPANIES AND SWOT ANALYSIS
    5.9 RECENT DEVELOPMENTS IN CANADA PHARMACEUTICAL SECTOR
    5.9.1 RECENT DRUGS APPROVED IN CANADA
    5.9.2 GLOBALLY APPROVED DRUGS LAUNCHED IN CANADA
    5.10 MEDICINE DISTRIBUTION SYSTEM
    5.11 PHARMACEUTICAL R&D SPENDING
    5.12 BIOTECHNOLOGY INDUSTRY OVERVIEW AND RECENT ADVANCEMENTS IN CANADA
    6 CANADA MEDICAL DEVICE MARKET
    6.1 MEDICAL DEVICE MARKET OVERVIEW AND FORECAST
    6.2 RECENT DEVELOPMENTS IN CANADA MEDICAL DEVICE SECTOR
    6.2.1 RECENT MEDICAL DEVICES APPROVED IN CANADA
    6.2.2 GLOBALLY APPROVED MEDICAL DEVICES LAUNCHED IN CANADA
    6.3 MEDICAL DEVICE RECALLS
    6.4 MAJOR COMPANIES AND SWOT ANALYSIS
    7. CANADA HEALTHCARE OVERVIEW AND EXPENDITURE
    7.1 HOSPITALS
    7.2 HEALTHCARE PERSONNEL
    7.3 HEALTHCARE EXPENDITURE
    7.4 PHARMACEUTICAL SPENDING
    7.5 MAJOR COMPONENTS OF HEALTHCARE EXPENDITURE
    8. CANADA HEALTHCARE MARKET OPPORTUNITY ASSESSMENT
    8.1 CANADA PHARMACEUTICAL MARKET OPPORTUNITIES
    8.1.1 EMERGING PHARMACEUTICAL COMPANIES
    8.1.2 UNIVERSITIES AND INSTITUTES- TECHNOLOGIES LICENSING OPPORTUNITY
    8.2 CANADA MEDICAL DEVICE MARKET OPPORTUNITIES
    8.2.1 EMERGING MEDICAL DEVICE COMPANIES
    8.2.2 UNIVERSITIES AND INSTITUTES- MEDICAL DEVICE TECHNOLOGIES LICENSING OPPORTUNITY
    9. PESTLE ANALYSIS
    10 MAJOR HEALTHCARE MERGERS & ACQUISITIONS IN CANADA
    11 ABBREVIATIONS
    LIST OF TABLES:
    TABLE 01: REPORT HIGHLIGHTS IN NUMERICALS
    TABLE 02: CANADA, PHARMACEUTICAL MARKET, 2012-2018
    TABLE 03: CANADA, PHARMACEUTICAL MARKET, 2019-2027
    TABLE 04: CANADA, PHARMACEUTICAL IMPORTS AND EXPORTS, 2012-2018
    TABLE 05: CANADA, PHARMACEUTICAL IMPORTS AND EXPORTS, 2019-2027
    TABLE 06: CANADA, PRESCRIPTION DRUGS MARKET, 2012-2018
    TABLE 07: CANADA, PRESCRIPTION DRUGS MARKET, 2019-2027
    TABLE 08: CANADA, PATENT DRUGS MARKET, 2012-2018
    TABLE 09: CANADA, PATENT DRUGS MARKET, 2019-2027
    TABLE 10: CANADA, GENERIC DRUGS MARKET, 2012-2018
    TABLE 11: CANADA, GENERIC DRUGS MARKET, 2019-2027
    TABLE 12: CANADA, OVER THE COUNTER DRUGS MARKET, 2012-2018
    TABLE 13: CANADA, OVER THE COUNTER DRUGS MARKET, 2019-2027
    TABLE 14: MAJOR PHARMACEUTICAL COMPANIES IN CANADA
    TABLE 15: LIST OF APPROVED DRUGS IN CANADA
    TABLE 16: LIST OF GLOBALLY APPROVED DRUGS LAUNCHED IN CANADA
    TABLE 17: CANADA, MEDICAL DEVICE MARKET, 2012-2028
    TABLE 18: CANADA MEDICAL DEVICE MARKET, 2019-2027
    TABLE 19: LIST OF MEDICAL DEVICES APPROVED IN CANADA
    TABLE 20: LIST OF GLOBALLY APPROVED MEDICAL DEVICES LAUNCHED IN CANADA
    TABLE 21: CANADA, NUMBER OF HOSPITALS, 2012-2018
    TABLE 22: CANADA, NUMBER OF HOSPITAL BEDS, 2012-2018
    TABLE 23: CANADA, PHYSICIANS (PER 1,000 POPULATION), 2012-2018
    TABLE 24: CANADA, NURSES (PER 1,000 POPULATION), 2012-2018
    TABLE 25: CANADA, PHARMACISTS (PER 1,000 POPULATION), 2012-2018
    TABLE 26: CANADA, HEALTH EXPENDITURE AS PERCENTAGE OF GDP (%), 2012-2018
    TABLE 27: LIST OF EMERGING PHARMACEUTICAL COMPANIES IN CANADA
    TABLE 28: PHARMA TECHNOLOGIES LICENSING OPPORTUNITIES BY UNIVERSITIES AND INSTITUTES
    TABLE 29: LIST OF EMERGING MEDICAL DEVICE COMPANIES IN CANADA
    TABLE 30: MEDICAL DEVICE TECHNOLOGIES LICENSING OPPORTUNITIES BY UNIVERSITIES AND INSTITUTES
    TABLE 31: MAJOR HEALTHCARE MERGERS AND ACQUISITIONS IN CANADA
    (ABOVE MENTIONED TABLES ARE A FEW AMONG THE TOTAL 96 TABLES IN THE REPORT)
    LIST OF FIGURES:
    FIGURE 01: CANADA, PHARMACEUTICAL MARKET, 2018 V/S 2027
    FIGURE 02: CANADA, PHARMACEUTICAL IMPORTS AND EXPORTS, 2018 V/S 2027
    FIGURE 03: CANADA, PRESCRIPTION DRUGS MARKET, 2018 V/S 2027
    FIGURE 04: CANADA, PATENT DRUGS MARKET, 2018 V/S 2027
    FIGURE 05: CANADA, GENERIC DRUGS MARKET, 2018 V/S 2027
    FIGURE 06: CANADA, OVER THE COUNTER DRUGS MARKET, 2018 V/S 2027
    FIGURE 07: CANADA, MEDICAL DEVICE MARKET, 2018 V/S 2027
    FIGURE 08: CANADA, NUMBER OF HOSPITALS, 2012 V/S 2018
    FIGURE 09: CANADA, NUMBER OF HOSPITAL BEDS (000’S), 2012 V/S 2018
    FIGURE 10: CANADA, PHYSICIANS (PER 1,000 POPULATION), 2012 V/S 2018
    FIGURE 11: CANADA, NURSES (PER 1,000 POPULATION), 2012 V/S 2018
    FIGURE 12: CANADA, PHARMACISTS (PER 1,000 POPULATION), 2012 V/S 2018
    FIGURE 13: CANADA, HEALTH EXPENDITURE AS PERCENTAGE OF GDP (%), 2012 V/S 2018
    FIGURE 14: MAJOR HEALTHCARE MERGERS AND ACQUISITIONS SCENARIO IN CANADA
    (ABOVE MENTIONED FIGURES ARE A FEW AMONG THE TOTAL 50 FIGURES IN THE REPORT)

Pricing

Individual Pricing $1000

Corporate Pricing $1000

Enterprise Pricing $1000

(We are offering all the above license types for a single price!!)